Application | Comment | Organism |
---|---|---|
medicine | structures helps to design new inhibitors that target LpxA, antibiotics | Escherichia coli |
Crystallization (Comment) | Organism |
---|---|
by using the hanging drop vapor diffusion method, in the presence of a 25-fold molar excess of either UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc or UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc, structures show how LpxA selects for 14-carbon R-3-hydroxyacyl chains and reveal two modes of UDP binding | Escherichia coli |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | P0A722 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(R)-3-hydroxymyristoyl-[acyl-carrier protein] + UDP-N-acetyl-alpha-D-glucosamine | first step in lipid A biosynthesis | Escherichia coli | [acyl-carrier protein] + UDP-3-O-(3-hydroxymyristoyl)-N-acetyl-alpha-D-glucosamine | - |
? | |
R-3-hydroxydecanoyl-[acyl carrier protein] + UDP-N-acetylglucosamine | first step in lipid A biosynthesis | Escherichia coli | [acyl-carrier protein] + UDP-3-O-hydroxydecanoyl-N-acetylglucosamine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
LpxA | - |
Escherichia coli |
UDP-N-acetylglucosamine acyltransferase | - |
Escherichia coli |